首页|期刊导航|中华医学杂志（英文版）|Drug treatment for metabolic dysfunction-associated steatotic liver disease:Progress and direction

Drug treatment for metabolic dysfunction-associated steatotic liver disease:Progress and direction

Da Zhou Jiangao Fan

中华医学杂志（英文版）2024，Vol.137Issue(22)：2687-2696,10.

中华医学杂志（英文版）2024，Vol.137Issue(22)：2687-2696,10.DOI:10.1097/CM9.0000000000003355

Drug treatment for metabolic dysfunction-associated steatotic liver disease:Progress and direction

Da Zhou ¹Jiangao Fan²

作者信息

1. Department of Gastroenterology and Hepatology,Zhongshan Hospital of Fudan University,Shanghai 200032,China||Shanghai Institute of Liver Diseases,Fudan University Shanghai Medical College,Shanghai 200032,China
2. Department of Gastroenterology,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200092,China||Shanghai Key Lab of Pediatric Gastroenterology and Nutrition,Shanghai 200092,China
折叠

摘要

关键词

Metabolic dysfunction-associated steatotic liver disease/Metabolic dysfunction-associated steatohepatitis/Non-alcoholic steatohepatitis/Non-alcoholic fatty liver disease/Pharmacotherapy/Clinical trial

Key words

引用本文复制引用

Da Zhou,Jiangao Fan..Drug treatment for metabolic dysfunction-associated steatotic liver disease:Progress and direction[J].中华医学杂志（英文版）,2024,137(22):2687-2696,10.

基金项目

This work was supported by grants from the National Science and Technology Major Project of China(No.2023ZD0508700)and the National Natural Science Foundation of China(No.82170593). （No.2023ZD0508700）

中华医学杂志（英文版）

OACSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航